Stock Market Reviews

Read and share opinions on COEP (Coeptis Therapeutics Holdings, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the s

Latest News

• Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
  Oct 1, 2025
• Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
  Jul 22, 2025
• Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
  May 28, 2025
• Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
  Mar 11, 2025
• COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
  Mar 7, 2025
• COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
  Feb 20, 2025
• Coeptis Therapeutics (COEP): Launching AI-Focused Venture Arm to Fuel Innovation
  Feb 13, 2025
• COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups
  Feb 13, 2025
• Coeptis Therapeutics Holdings, Inc. (COEP) Raises $10M to Advance AI-Driven Cell Therapy Innovations
  Feb 8, 2025
• COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration
  Feb 6, 2025
• Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation
  Jan 31, 2025
• Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
  Jan 30, 2025
• Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
  Jan 23, 2025
• Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
  Jan 22, 2025
• Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
  Jan 7, 2025
• Why Is Coeptis Therapeutics Stock Falling On Friday?
  Dec 27, 2024
• Coeptis Therapeutics Announces Reverse Stock Split
  Dec 27, 2024
• Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
  Dec 26, 2024
• Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies
  Dec 12, 2024
• Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries
  Dec 3, 2024